Limitations of postmarketing surveillance in the analysis of risk of pregnancy loss associated with maternal mefloquine exposure
- PMID: 22761410
- DOI: 10.1093/cid/cis601
Limitations of postmarketing surveillance in the analysis of risk of pregnancy loss associated with maternal mefloquine exposure
Comment on
-
Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy.Clin Infect Dis. 2012 Jun;54(11):e124-31. doi: 10.1093/cid/cis215. Epub 2012 Apr 10. Clin Infect Dis. 2012. PMID: 22495078 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
